首页> 外文期刊>PLoS One >Lower DNA methylation levels in CpG island shores of CR1 , CLU , and PICALM in the blood of Japanese Alzheimer’s disease patients
【24h】

Lower DNA methylation levels in CpG island shores of CR1 , CLU , and PICALM in the blood of Japanese Alzheimer’s disease patients

机译:在日本阿尔茨海默病患者血液中降低CPG岛海岸的DNA甲基化水平,在日本阿尔茨海默病患者的血液中

获取原文
           

摘要

The aim of the present study was to (1) investigate the relationship between late-onset Alzheimer’s disease (AD) and DNA methylation levels in six of the top seven AD-associated genes identified through a meta-analysis of recent genome wide association studies, APOE , BIN1 , PICALM , CR1 , CLU , and ABCA7 , in blood, and (2) examine its applicability to the diagnosis of AD. We examined methylation differences at CpG island shores in the six genes using Sanger sequencing, and one of two groups of 48 AD patients and 48 elderly controls was used for a test or replication analysis. We found that methylation levels in three out of the six genes, CR1 , CLU , and PICALM , were significantly lower in AD subjects. The combination of CLU methylation levels and the APOE genotype classified AD patients with AUC = 0.84 and 0.80 in the test and replication analyses, respectively. Our study implicates methylation differences at the CpG island shores of AD-associated genes in the onset of AD and suggests their diagnostic value.
机译:本研究的目的是(1)调查通过近期基因组宽协会研究鉴定的六个七种患有六种患有六个患者的六种六种患有六种患者的六种甲基化水平之间的关系, Apoe,Bin1,Picalm,Cr1,Clu和Abca7,血液和(2)检查其对广告诊断的适用性。我们在使用Sanger测序中检查了六个基因中CpG岛海岸的甲基化差异,并使用两组48名AD患者和48名老年人对照中的一个用于测试或复制分析。我们发现,在六种基因中,在六个基因,Cr1,Clu和Piccalm中的三种甲基化水平在AD受试者中显着降低。 Clu甲基化水平和ACOE基因型分类AD患者的组合分别在试验和复制分析中AUC = 0.84和0.80患者。我们的研究暗示了广告发作中的AD相关基因的CPG岛海岸的甲基化差异,并表明了它们的诊断价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号